Physician profile
Saad Alkaade
NPI 1033433594
$1,277.01
in general payments reported to CMS, 2019-2025
22 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.41 · 2021: $119 · 2022: $256 · 2023: $258 · 2024: $382 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.77 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $126.79 | 2023 | Breztri |
| Erbe USA INC | $113.36 | 2025 | Vio3 |
| Novo Nordisk INC | $112.22 | 2024 | |
| Genzyme Corporation | $99.55 | 2022 | |
| Pfizer INC. | $92.40 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $70.06 | 2024 | Xarelto |
| Kci USA, INC. | $66.08 | 2019 | |
| Merck Sharp & Dohme LLC | $65.81 | 2022-2024 | Dificid, Zerbaxa |
| Cumberland Pharmaceuticals, INC. | $63.46 | 2022-2024 | Caldolor |
| Novartis Pharmaceuticals Corporation | $56.26 | 2023-2024 | |
| Amgen INC. | $42.34 | 2022 | |
| Mallinckrodt Hospital Products INC. | $38.36 | 2023-2024 | Terlivaz |
| Medtronic, INC. | $30.73 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.39 | 2024 | Xifaxan |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $21.33 | 2019 | |
| Lilly USA, LLC | $20.58 | 2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $19.91 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.13 | 2021 | |
| Exact Sciences Corporation | $18.61 | 2025 | Cologuard Collection Kit |
| Neurelis, INC. | $18.27 | 2023 | Valtoco |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.60 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saad Alkaade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.